Document Detail


The Bolton Treovance abdominal stent-graft: European clinical trial design.
MedLine Citation:
PMID:  22955554     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Endovascular aortic repair (EVAR) has emerged as a promising, less invasive alternative to conventional open surgery for the treatment of infrarenal abdominal aortic aneurysms (AAAs). In the last 20 years, the application rate of EVAR and its clinical results have significantly improved thanks to the evolution of stent-grafts and endovascular delivery systems. However, further development is still needed to reduce the incidence of complications and secondary re-interventions. The Treovance abdominal aortic stent-graft (Bolton Medical, Barcelona, Spain) is a new-generation endovascular device, developed to increase flexibility, lower profile, improve deployment and sealing mechanisms. In particular, it is provided with some innovative features as a double layer of proximal barbs (suprarenal and infrarenal) for supplemental fixation, dull barbs between modules to avoid potential leg disconnections, detachable outer sheath provided with a new-design hemostatic valve, and a double improved mechanism (slow motion and "pin and pull") for precise stent-graft deployment. A European prospective, non-randomized, multi-institutional, "first-in-human" trial (the ADVANCE trial) was conducted from March to December 2011 to assess the safety and performance of the Treovance stent-graft system before commercialization. Thirty patients with anatomically suitable non-ruptured AAAs were enrolled at five clinical sites in Italy, Spain, and Germany. EVAR was completed successfully in all patients. The stent-graft was delivered and deployed safely even in heavily angulated or calcified anatomies. No 30-day device-related complications nor deaths were observed. Preliminary experience with the Treovance abdominal stent-graft within the ADVANCE trial was satisfactory with regard to technical success and perioperative clinical results. Follow-up data are needed to assess mid- and long-term clinical outcomes, along with durability of this new-generation endovascular device.
Authors:
R Chiesa; V Riambau; G Coppi; B Zipfel; S Llagostera; E M Marone; A Kahlberg
Related Documents :
24947564 - The analysis of ascending aortic dilatation in patients with a bicuspid aortic valve us...
24897974 - Pulmonary arterial hypertension in childhood: an unsual presentation with fibrosing med...
23260434 - Importance of false lumen thrombosis in type b aortic dissection prognosis.
25047224 - Bioprosthetic mitral valve thrombosis complicating antiphospholipid antibody syndrome, ...
2301264 - In vivo identification of mitral valve fibrosis and calcium by real-time quantitative u...
12369664 - The normal offset of the tricuspid septal leaflet in the fetus.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of cardiovascular surgery     Volume:  53     ISSN:  0021-9509     ISO Abbreviation:  J Cardiovasc Surg (Torino)     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-09-07     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0066127     Medline TA:  J Cardiovasc Surg (Torino)     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  595-604     Citation Subset:  IM    
Affiliation:
San Raffaele Scientific Institute, Vita-Salute University School of Medicine, Milan, Italy - kahlberg.andrea@hsr.it.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The use of Endurant stent-graft for abdominal aortic aneurysm: the story about extension of Instruct...
Next Document:  Body of knowledge around the diabetic foot and limb salvage.